Bristol Myers Squibb BMY
NYSE BMY
$63.03 +0.20 (+0.32%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Other Working Capital Changes (2009 - 2026)

Bristol Myers Squibb's (BMY) quarterly Other Working Capital Changes came in at $3.6 billion in Q3 2012, up 17328.57% year-over-year from N/an in Q4 2011, and up 8313.95% quarter-over-quarter from $43.0 million in Q2 2012.

Analysis

Bristol Myers Squibb (BMY) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Other Working Capital Changes for 4 consecutive years, with $3.6 billion the latest figure, recorded in Q3 2012.

  • On a quarterly basis, Other Working Capital Changes rose 17328.57% year-over-year to $3.6 billion in Q3 2012; TTM through Dec 2012 was $3.6 billion, a 3204.35% increase from a year earlier, with the FY2012 full-year figure at $3.6 billion, up 3204.35% from the prior year.
  • Other Working Capital Changes was $3.6 billion for Q3 2012 at Bristol Myers Squibb, up from $43.0 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1.6 billion in Q1 2026 and troughed at -$1.1 billion in Q4 2025.
  • A 5-year average of $57.3 million and a median of -$170.0 million in 2023 frame the typical range for Other Working Capital Changes.
  • Across the five-year window, Other Working Capital Changes sank 262.86% in 2011 and surged 17328.57% in 2012, its largest moves.
  • Over 4 years, Other Working Capital Changes stood at $60.0 million in 2009, then jumped by 93.33% to $116.0 million in 2010, then slumped by 96.55% to $4.0 million in 2011, then surged by 90350.0% to $3.6 billion in 2012.
  • The last three Other Working Capital Changes figures came in at $3.6 billion (Q3 2012), $43.0 million (Q2 2012), and -$91.0 million (Q1 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -786.00 Mn
Jun 30, 2026 -786.00 Mn
Mar 31, 2026 1.64 Bn
Mar 31, 2026 1.64 Bn
Dec 31, 2025 -1.07 Bn
Dec 31, 2025 -1.07 Bn
Sep 30, 2025 -240.00 Mn
Sep 30, 2025 -240.00 Mn
Jun 30, 2025 -222.00 Mn
Jun 30, 2025 -222.00 Mn
Mar 31, 2025 1.06 Bn
Mar 31, 2025 1.06 Bn
Dec 31, 2024 -725.00 Mn
Dec 31, 2024 -725.00 Mn
Sep 30, 2024 -167.00 Mn
Sep 30, 2024 -167.00 Mn
Jun 30, 2024 -340.00 Mn
Jun 30, 2024 -340.00 Mn
Mar 31, 2024 608.00 Mn
Mar 31, 2024 608.00 Mn